Early Changes in Kidney Transplant Immunosuppression Regimens During the COVID-19 Pandemic-Reference-Cited by-同舟云学术

Early Changes in Kidney Transplant Immunosuppression Regimens During the COVID-19 Pandemic

Published:2020-10-21 Issue:1 Volume:105 Page:170-176
ISSN:0041-1337
Container-title:Transplantation
language:en
Short-container-title:

Author:

Bae Sunjae,McAdams-DeMarco Mara A.,Massie Allan B.,Ahn JiYoon B.,Werbel William A.,Brennan Daniel C.,Lentine Krista L.,Durand Christine M.,Segev Dorry L.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Transplantation

Reference28 articles.

1. Rabbit antithymocyte globulin versus basiliximab in renal transplantation.;Brennan;N Engl J Med,2006

2. Tacrolimus versus ciclosporin as primary immunosuppression for kidney transplant recipients: meta-analysis and meta-regression of randomised trial data.;Webster;BMJ,2005

3. Long-term immunosuppression, without maintenance prednisone, after kidney transplantation.;Matas;Ann Surg,2004

4. A prospective, randomized, double-blind, placebo-controlled multicenter trial comparing early (7 day) corticosteroid cessation versus long-term, low-dose corticosteroid therapy.;Woodle;Ann Surg,2008

5. Infection in solid-organ transplant recipients.;Fishman;N Engl J Med,2007

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Transplantation in the Pandemic Era: Perspectives on the Utilization of COVID-19 Positive Organs;Transplantation Proceedings;2024-07

2. COVID-19 and renal allograft rejection: insight from controlled and non-controlled studies;Renal Failure;2024-04-16

3. Outcomes of Kidney Transplantation Among COVID-19 Recovered Patients in a Single Transplant Center;Transplantation Proceedings;2024-04

4. Impact of Cumulative 6 mg/kg Antithymocyte Globulin on Early Posttransplant Outcomes in Kidney Transplant Recipients with Delayed Graft Function;Progress in Transplantation;2024-03-11

5. The analysis of low-dose glucocorticoid maintenance therapy in patients with primary nephrotic syndrome suffering from COVID-19;Frontiers in Molecular Biosciences;2024-01-11